Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq
Affected assets and topics
Why it matters
Cybin Inc. plans to transfer its U.S. stock exchange listing from NYSE American to Nasdaq Global Market, expecting its common shares to cease trading on NYSE American upon completion.
Expected market reaction
Market impact analysis based on neutral sentiment with 78% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 24021
Original source
TORONTO, December 18, 2025--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) , a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by developing innovative next-generation treatment options, today announced that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global Market ("Nasdaq") from the NYSE American LLC ("NYSE American"). The Company expects that its common shares will cease trading on the NYSE American at market clo
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on December 18, 2025. Analysis and insights provided by AnalystMarkets AI.
This model on similar stories
Llama 3.1 8B Instant (Groq) · 37.9% correct across 177 scored calls on equities See the full record